NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 107 filers reported holding NGM BIOPHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $29,415 | +21.2% | 18,500 | -34.5% | 0.00% | – |
Q4 2023 | $24,268 | -98.4% | 28,251 | -98.0% | 0.00% | – |
Q3 2023 | $1,513,062 | +6.8% | 1,414,076 | +158.6% | 0.00% | – |
Q2 2023 | $1,416,412 | -35.7% | 546,877 | +1.3% | 0.00% | – |
Q1 2023 | $2,202,000 | +77298.9% | 539,862 | -4.7% | 0.00% | – |
Q4 2022 | $2,845 | -100.0% | 566,539 | +6.1% | 0.00% | -100.0% |
Q3 2022 | $6,983,000 | -1.4% | 533,897 | -3.4% | 0.00% | 0.0% |
Q2 2022 | $7,083,000 | -13.0% | 552,541 | +3.5% | 0.00% | 0.0% |
Q1 2022 | $8,142,000 | -26.2% | 533,921 | -14.2% | 0.00% | 0.0% |
Q4 2021 | $11,026,000 | -16.4% | 622,538 | -0.7% | 0.00% | -50.0% |
Q3 2021 | $13,182,000 | +9.1% | 627,118 | +2.3% | 0.00% | +100.0% |
Q2 2021 | $12,086,000 | +137.1% | 612,873 | +249.5% | 0.00% | 0.0% |
Q1 2021 | $5,097,000 | -12.4% | 175,332 | -8.7% | 0.00% | 0.0% |
Q4 2020 | $5,819,000 | +77.9% | 192,094 | -5.4% | 0.00% | 0.0% |
Q3 2020 | $3,271,000 | -24.1% | 203,014 | -7.0% | 0.00% | 0.0% |
Q2 2020 | $4,311,000 | +43.7% | 218,351 | -10.3% | 0.00% | 0.0% |
Q1 2020 | $3,001,000 | -43.1% | 243,442 | -14.7% | 0.00% | 0.0% |
Q4 2019 | $5,274,000 | +16912.9% | 285,265 | +12635.0% | 0.00% | – |
Q3 2019 | $31,000 | +14.8% | 2,240 | +21.3% | 0.00% | – |
Q2 2019 | $27,000 | – | 1,847 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|